Now I have all the information needed. Let me construct the final consolidated review.

---

## Summary

This paper presents two main contributions: TrASPr, a multi-transformer model for tissue-specific splicing prediction that centers separate transformers on each of the four splice sites of a cassette exon and incorporates pre-training on splice-site sequences; and BOS, a Bayesian optimization framework that uses TrASPr as an oracle to design RNA sequences with desired splicing outcomes under edit-distance constraints. The model is evaluated on GTEx and MGP datasets, ENCODE RBP knockdown experiments, and a Daam1 mini-gene reporter assay, with the BOS algorithm compared against random mutation and genetic algorithm baselines.

## Strengths

- **Novel, biologically motivated architecture**: TrASPr's design of centering separate transformers on each of the four splice sites (rather than using a monolithic window) is a principled way to handle the variable-length, multi-region nature of cassette exon regulation. The paper clearly motivates why existing approaches like SpliceAI/Pangolin's 10Kb window are insufficient for many cassette exons (Section 1, paragraph 6).

- **Independent biological validation**: TrASPr correctly predicts the direction of splicing changes upon RBP knockdown with statistical significance (over 50% correct, p=0.0001; correlation 0.34, p=0.0192; Section 4.3, Figure 4c) and correctly predicts mutation effects in 7/9 cases from a Daam1 mini-gene reporter assay (p=0.0012, Figure 5a). These validations against independent experimental data go beyond standard benchmark comparisons.

- **First formulation of splicing sequence design as constrained optimization**: The paper identifies and formalizes a genuinely new problem — designing sequences for tissue-specific splicing outcomes under an edit-distance budget — and adapts latent-space Bayesian optimization (LOL-BO with SCBO) to solve it. This opens a new direction for the field.

- **Informative ablation studies**: The ablation study (Table 2) systematically isolates the contribution of pre-training (noPre), extra features (noFeat), and the transformer architecture (wLSTM), demonstrating that each component contributes meaningfully to overall performance.

- **Cross-species generalization**: The model is trained on both human (GTEx) and mouse (MGP) data and successfully predicts splicing changes in human ENCODE KD experiments and a mouse mini-gene assay, demonstrating broad applicability.

## Weaknesses

### Fatal
None.

### Major

- **Pangolin comparison for PSI prediction is not a valid apples-to-apples baseline**: The paper claims state-of-the-art PSI prediction (Pearson 0.81 vs 0.17, Figure 2), but Pangolin was designed to predict per-position "splice usage" from a 10Kb window, not event-level PSI for a specific cassette exon. The paper acknowledges Pangolin "is unable to define specific splicing events such as cassette exons" and adapts it by averaging splice site outputs. There is no evidence this average corresponds to cassette exon PSI, and the paper itself notes that Pangolin's authors "reported moderate accuracy for tissue-specific splicing prediction." The massive gap (0.81 vs 0.17) is inherently suspicious and likely reflects the task mismatch rather than TrASPr's superiority. This comparison cannot bear the weight of the headline "state-of-the-art" claim. The paper needs a properly retrained event-level baseline (e.g., adapting SpliceAI or MT-Splice for the same task and training data) to substantiate this claim.

- **Data leakage acknowledged in dPSI comparison on MGP**: The paper reports that applying a more stringent filtering to remove test exons similar to training exons causes TrASPr's performance to degrade while AE+MLP's performance improves (Section 4.1, line 124). The authors explain that the removed examples had labels correlated with training samples, "giving TrASPr an advantage." This is a direct admission that the standard test set evaluation inflates TrASPr's apparent advantage due to sequence overlap/homology. The primary dPSI results in Table 1/Figure 3 are therefore not established on a properly leakage-controlled evaluation. The paper should report both models' performance under the stringent filter and discuss what the narrowed gap implies for the claimed improvement.

### Minor

- **Missing comparisons to other event-level models**: The paper mentions MT-Splice (CNN-based) and other deep-learning splicing models in the introduction but provides no empirical comparison to them. Only Pangolin (for PSI) and AE+MLP from Jha et al. (2017) (for dPSI) are compared. Given that MT-Splice and similar models were also designed for mutation effect prediction on cassette exons, their absence weakens the thoroughness of the evaluation.

- **BOS evaluation is entirely in silico with no experimental validation**: The paper explicitly scopes this ("we assume the Oracle is correct and only assess the ability to efficiently generate candidate sequences," line 168), which is fair. However, the claims that BOS "effectively capture regulatory elements" and generates "biologically plausible mutations" are conclusions drawn from computational analysis alone — no synthesized sequences are tested in vitro. The BOS results remain a computational proof-of-concept, and the paper would benefit from more measured language about biological discovery.

- **No confidence intervals or variance reported for BOS results**: The BOS comparisons (30.3% vs 4.03% and 4.7% success rate, Figure 6) report a single run with no confidence intervals, error bars, or statistical significance tests. The improvement is large, but variance across random seeds is not assessed.

- **VAE training details for BOS are underspecified**: The VAE is described as a "6 layer Transformer encoder/decoder," but no details on latent dimension, regularization, training loss for the VAE, or how the Levenshtein constraint is incorporated into the SCBO acquisition function are provided (Section 3.2).

### Trivial
- Some figures (Table 2 ablation numbers, Table 1 dPSI results) are embedded as images and their numerical values are not discussed in the body text, making it difficult to assess exact magnitudes.

## Nice-to-Haves

- Comparing TrASPr to a properly retrained event-level model (e.g., MT-Splice or a SpliceAI adaptation) on the same GTEx splits would strengthen the PSI prediction claim far more than the Pangolin comparison.
- Reporting results on the stringently filtered MGP test set (with both models' exact numbers) would clarify how much the leakage issue affects relative performance.
- Experimental validation of even a handful of BOS-designed sequences (e.g., via mini-gene reporter) would significantly increase confidence in the design framework.
- Attention maps from the four splice-site transformers would help illustrate what the model learns about regulatory elements.

## Removed Points

These points are flagged to be removed; treat them with caution.

- **"The Pangolin adaptation is completely invalid"** — softened to Major. The paper is transparent about the adaptation and caveats it. The comparison is informative as an upper/lower bound reference, but cannot support a SOTA claim without a proper event-level baseline.
- **"The wLSTM ablation results are implausibly low and suggest a broken training setup"** — the wLSTM model replaces both the transformer AND removes features (Table 2 caption: "without the extra features"), making it a double ablation. The poor performance is not implausible given this combined handicap.
- **"No experimental validation of BOS"** — the paper explicitly scopes this out ("we assume the Oracle is correct and only assess the ability to efficiently generate candidate sequences"). Criticism of missing experiments beyond the stated scope is weakened, though the overclaiming about biological discovery remains a valid concern.
- **"The noPre model comparison is unfair because it might need more epochs"** — the paper states it "converges slower," which is precisely the point of the ablation: pre-training enables faster convergence. This is a standard and valid ablation.
- **"p-values could be inflated by selection or multiple testing"** — no evidence of this is provided, and the reported p-values (0.0001, 0.0012, 0.0192) use standard tests.
- **Pure formatting/style nitpicks and complaints about parser-stripped content** (missing appendix content, proofs, references) — removed per instructions.

## Novel Insights

None beyond the paper's own contributions. The reviews do not surface a perspective on the paper that the authors themselves have not already articulated or could not reasonably address.

## Suggestions

1. **Retract or reframe the Pangolin comparison**: Either retrain Pangolin (or another event-level model) on the same task and training data, or reframe the comparison as an illustrative reference showing how task mismatch affects performance, rather than as evidence of state-of-the-art prediction.
2. **Report the stringently filtered results for both models**: Provide exact AUROC/AUPRC numbers under both standard and stringent filtering for TrASPr and AE+MLP on the MGP dataset, and discuss the implications for the claimed improvement.
3. **Add confidence intervals to the BOS evaluation**: Run BOS, random mutation, and GA with multiple random seeds and report means and standard deviations or confidence intervals.
4. **Tone down claims about BOS discovering regulatory elements**: Without experimental validation, claims about "effectively capturing regulatory elements" should be qualified as computational hypotheses.
5. **Provide a simple comparison to MT-Splice or similar**: Even applying a publicly available model to the same test data without retraining would help contextualize TrASPr's performance within the broader literature.

## Score and Decision

The paper introduces a genuinely novel architecture (TrASPr) that is biologically well-motivated, and formulates a new problem (splicing sequence design) that could be impactful. The independent biological validation (RBP KD, mini-gene) provides meaningful support. However, the headline PSI prediction claim rests on a comparison to Pangolin that is fundamentally compromised by task mismatch, and the dPSI comparison against AE+MLP is undermined by the authors' own admission of data leakage. The BOS contribution, while novel, remains a proof-of-concept. These issues do not invalidate the paper's core ideas, but they mean the current evidence does not adequately support the strength of the claims made, particularly the "state-of-the-art" assertion. Major revisions addressing the Pangolin comparison and leakage issue are needed before the paper meets the bar for acceptance.

MY FINAL SCORE: <pineapple>5.0</pineapple>
MY FINAL DECISION: <orange>Reject</orange>